Loading clinical trials...
Loading clinical trials...
EXODUS: Extracorporeal Lung Assist Device in Acute Lung Impairment: A Randomized Controlled Study
Conditions
Interventions
iLA activve treatment
Control group
Locations
8
Austria
Medical University of Vienna/General Hospital of Vienna
Vienna, Austria
Klinik für Intensivmedizin; Universitätsklinikum Hamburg-Eppendorf (UKE)
Hamburg, Germany
Abteilung für Intensivmedizin; Krankenhaus Barmherzige Brüder; München
Munich, Germany
I. Medizinische Klinik; Klinikum rechts der Isar; Technische Universität München
Munich, Germany
II. Medizinische Klinik; Klinikum rechts der Isar; Technische Universität München
München, Germany
Klinik für Anästhesiologie; Klinikum rechts der Isar; Technische Universität München
München, Germany
Start Date
November 1, 2015
Primary Completion Date
July 1, 2017
Completion Date
December 1, 2017
Last Updated
September 15, 2015
NCT07450846
NCT07414056
NCT06701669
NCT07262541
NCT07086755
NCT06876415
Lead Sponsor
Technical University of Munich
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions